Petrus van Veelen
- Naam
- Dr. P.A. van Veelen
- Telefoon
- +31 71 526 4656
- p.a.van_veelen@lumc.nl
- Faculteit Geneeskunde
- Divisie 4
- Immunologie
- IHB algemeen
- Claushuis, B.; Ru, A.H. de; Rotman, S.A.; Veelen, P.A. van; Dawson, L.F.; Wren, B.W.; Corver, J.; Smits, W.K. & Hensbergen, P.J. (2023), Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δerm Based on Quantitative Proteomics of cd0241-cd0244 Mutant Strains, ACS Infectious Diseases 9(12): 2665-2674.
- Holborough-Kerkvliet, M.D.; Mucignato, G.; Moons, S.J.; Psomiadou, V.; Konada, R.S.R.; Pedowitz, N.J.; Pratt, M.R.; Kissel, T.; Koeleman, C.A.M.; Tjokrodirijo, R.T.N.; Veelen, P.A. van; Huizinga, T.; Schie, K.A.J. van; Wuhrer, M.; Kohler, J.J.; Bonger, K.M.; Boltje, T.J. & Toes, R.E.M. (2023), A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners, Glycobiology 33(9): 732-744.
- Dinther, M. van; Cunningham, K.T.; Singh, S.P.; White, M.P.J.; Campion, T.; Ciancia, C.; Veelen, P.A. van; Ru, A.H. de; González-Prieto, R.; Mukundan, A.; Byeon, C.H.; Staggers, S.R.; Hinck, C.S.; Hinck, A.P.; Dijke, P. ten & Maizels, R.M. (2023), CD44 acts as a coreceptor for cell- specific enhancement of signaling and regulatory T cell induction by TGM1, a parasite TGF-β mimic, Proceedings of the National Academy of Sciences 120(34).
- Salas-Lloret, D.; Jansen, N.S.; Nagamalleswari, E.; Meulen, C. van der; Gracheva, E.; Ru, A.H. de; Otte, H.A.M.; Veelen, P.A. van; Pichler, A.; Goedhart, J.; Vertegaal, A.C.O. & González-Prieto, R. (2023), SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome, Science Advances 9(31).
- Cremer, T.; Voortman, L.M.; Bos, E.; Jongsma, M.L.M.; Haar, L.R. ter; Akkermans, J.J.L.L.; Ormeno, C.M.T.; Wijdeven, R.H.; Vries, J. de; Kim, R.Q.; Janssen, G.M.C.; Veelen, P.A. van; Koning, R.I.; Neefjes, J. & Berlin, I. (2023), RNF26 binds perinuclear vimentin filaments to integrate ER and endolysosomal responses to proteotoxic stress, The EMBO Journal 42(18).
- Claushuis, B.; Cordfunke, R.A.; Ru, A.H. de; Otte, A.; Leeuwen, H.C. van; Klychnikov, O.I.; Veelen, P.A. van; Corver, J.; Drijfhout, J.W. & Hensbergen, P.J. (2023), In-depth specificity profiling of endopeptidases using dedicated mix-and-split synthetic peptide libraries and mass spectrometry, Analytical Chemistry 95(31): 11621-11631.
- Abendstein, L.; Dijkstra, D.J.; Tjokrodirijo, R.T.N.; Veelen, P.A. van; Trouw, L.A.; Hensbergen, P.J. & Sharp, T.H. (2023), Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains, Nature Communications 14(1).
- Wang, W.; Zhang, T.; Nouta, J.; Veelen, P.A. van; Haan, N. de; Reijke, T.M. de; Wuhrer, M. & Lageveen-Kammeijer, G.S.M. (2023), Human Prostate-Specific Antigen Carries N-Glycans with Ketodeoxynononic Acid, Engineering 26: 119-131.
- Fan, C.N.; González-Prieto, R.; Kuipers, T.B.; Vertegaal, A.C.O.; Veelen, P.A. van; Mei, H.L. & Dijke, P. ten (2023), The lncRNA LETS1 promotes TGF-β-induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism, Science Signaling 16(790).
- Kooij, B. van de; Vries, E. de; Rooswinkel, R.W.; Janssen, G.M.C.; Kok, F.K.; Veelen, P.A. van & Borst, J. (2023), N-terminal acetylation can stabilize proteins independent of their ubiquitination, Scientific Reports 13(1).
- Amerongen, R.A. van; Tuit, S.; Wouters, A.K.; Meent, M. van de; Siekman, S.L.; Meeuwsen, M.H.; Wachsmann, T.L.A.; Remst, D.F.G.; Hagedoorn, R.S.; Steen, D.M. van der; Ru, A.H. de; Verdegaal, E.M.E.; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2023), PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer, Frontiers in Immunology 14.
- Rooij, M.A.J. de; Remst, D.F.G.; Steen, D.M. van der; Wouters, A.K.; Hagedoorn, R.S.; Kester, M.G.D.; Meeuwsen, M.H.; Wachsmann, T.L.A.; Ru, A.H. de; Veelen, P.A. van; Verdegaal, E.M.E.; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2023), A library of cancer testis specific T cell receptors for T cell receptor gene therapy, Molecular Therapy - Oncolytics 28.
- Madunic, K.; Luijkx, Y.M.C.A.; Mayboroda, O.A.; Janssen, G.M.C.; Veelen, P.A.V.; Strijbis, K.; Wennekes, T.; Lageveen-Kammeijer, G.S.M. & Wuhrer, M. (2023), O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation, Molecular & Cellular Proteomics 22(3).
- Meeuwsen, M.H.; Wouters, A.K.; Wachsmann, T.L.A.; Hagedoorn, R.S.; Kester, M.G.D.; Remst, D.F.G.; Steen, D.M. van der; Ru, A.H. de; Hees, E.P. van; Kremer, M.; Griffioen, M.; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2023), Broadly applicable TCR-based therapy for multiple myeloma targeting the immunoglobulin J chain, Journal of Hematology and Oncology 16(1).
- Treffers, E.E.; Tas, A.; Scholte, F.E.M.; Ru, A.H. de; Snijder, E.J.; Veelen, P.A. van & Hemert, M.J. van (2023), The alphavirus nonstructural protein 2 NTPase induces a host translational shut-off through phosphorylation of eEF2 via cAMP-PKA-eEF2K signaling, PLoS Pathogens 19(2).
- Venema, W.J.; Hiddingh, S.; Janssen, G.M.C.; Norel, J.O.V.; Loon, N.D. van; Boer, J.H. de; Veelen, P.A. van & Kuiper, J.J.W. (2023), Retina-arrestin specific CD8+T cells are not implicated in HLA-A29-positive birdshot chorioretinitis, Clinical Immunology 247.
- Tuerlings, M.; Janssen, G.M.C.; Boone, I.; Hoolwerff, M. van; Ruiz, A.R.; Houtman, E.; Suchiman, H.E.D.; Wal, R.J.P. van der; Nelissen, R.G.H.H.; Almeida, R.C. de; Veelen, P.A. van; Ramos, Y.F.M. & Meulenbelt, I. (2023), WWP2 confers risk to osteoarthritis by affecting cartilage matrix deposition via hypoxia associated genes, Osteoarthritis and Cartilage 31(1): 39-48.
- Ruibal, P.; Franken, K.L.M.C.; Meijgaarden, K.E.V.; Wolfswinkel, M. van; Derksen, I.; Scheeren, F.A.; Janssen, G.M.C.; Veelen, P.A. van; Sarfas, C.; White, A.D.; Sharpe, S.A.; Palmieri, F.; Petrone, L.; Goletti, D.; Abeel, T.; Ottenhoff, T.H.M. & Joosten, S.A. (2022), Identification of HLA-E binding Mycobacterium tuberculosis-derived epitopes through improved prediction models, The Journal of Immunology 209(8): 1555-1565.
- Ruibal, P.; Franken, K.L.M.C.; Meijgaarden, K.E.V.; Wolfswinkel, M. van; Derksen, I.; Scheeren, F.A.; Janssen, G.M.C.; Veelen, P.A. van; Sarfas, C.; White, A.D.; Sharpe, S.A.; Palmieri, F.; Petrone, L.; Goletti, D.; Abeel, T.; Ottenhoff, T.H.M. & Joosten, S.A. (2022), Identification of HLA-E Binding Mycobacterium tuberculosis-Derived Epitopes through Improved Prediction Models, The Journal of Immunology 209(8): 1555-1565.
- Hos, B.J.; Tondini, E.; Camps, M.G.M.; Rademaker, W.; Bulk, J. van den; Ruano, D.; Janssen, G.M.C.; Ru, A.H. de; Elsen, P.J. van den; Miranda, N.F.C.C. de; Veelen, P.A. van & Ossendorp, F. (2022), Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITA, Cell Reports 41(2).
- Pan, K. van der; Kassem, S.; Khatri, I.; Ru, A.H. de; Janssen, G.M.C.; Tjokrodirijo, R.T.N.; Makindji, F. al; Stavrakaki, E.; Jager, A.L. de; Naber, B.A.E.; Laat, I.F. de; Louis, A.; Bossche, W.B.L. van den; Vogelezang, L.B.; Balvers, R.K.; Lamfers, M.L.M.; Veelen, P.A. van; Orfao, A.; Dongen, J.J.M. van; Teodosio, C. & Díez, P. (2022), Quantitative proteomics of small numbers of closely-related cells: Selection of the optimal method for a clinical setting, Frontiers in Medicine 9.
- Pan, K. van der; Kassem, S.; Khatri, I.; Ru, A.H. de; Janssen, G.M.C.; Tjokrodirijo, R.T.N.; Makindji, F. al; Stavrakaki, E.; Jager, A.L. de; Naber, B.A.E.; Laat, I.F. de; Louis, A.; Bossche, W.B.L. van den; Vogelezang, L.B.; Balvers, R.K.; Lamfers, M.L.M.; Veelen, P.A. van; Orfao, A.; Dongen, J.J.M. van; Teodosio, C. & Diez, P. (2022), Quantitative proteomics of small numbers of closely-related cells, Frontiers in Medicine 9.
- Noone, D.P.; Dijkstra, D.J.; Klugt, T.T. van der; Veelen, P.A. van; Ru, A.H. de; Hensbergen, P.J.; Trouw, L.A. & Sharp, T.H. (2022), PTX3 structure determination using a hybrid cryoelectron microscopy and AlphaFold approach offers insights into ligand binding and complement activation, Proceedings of the National Academy of Sciences 119(33).
- Amerongen, R.A. van; Hagedoorn, R.S.; Remst, D.F.G.; Assendelft, D.C.; Steen, D.M. van der; Wouters, A.K.; Meent, M. van de; Kester, M.G.D.; Ru, A.H. de; Griffioen, M.; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2022), WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma, Journal for ImmunoTherapy of Cancer 10(6).
- Rossi, M.; Altea-Manzano, P.; Demicco, M.; Doglioni, G.; Bornes, L.; Fukano, M.; Vandekeere, A.; Cuadros, A.M.; Fernandez-Garcia, J.; Riera-Domingo, C.; Jauset, C.; Planque, M.; Alkan, H.F.; Nittner, D.; Zuo, D.M.; Broadfield, L.A.; Parik, S.; Pane, A.A.; Rizzollo, F.; Rinaldi, G.; Zhang, T.; Teoh, S.T.; Aurora, A.B.; Karras, P.; Vermeire, I.; Broekaert, D.; Elsen, J. van; Knott, M.M.L.; Orth, M.F.; Demeyer, S.; Eelen, G.; Dobrolecki, L.E.; Bassez, A.; Brussel, T. van; Sotlar, K.; Lewis, M.T.; Bartsch, H.; Wuhrer, M.; Veelen, P. van; Carmeliet, P.; Cools, J.; Morrison, S.J.; Marine, J.C.; Lambrechts, D.; Mazzone, M.; Hannon, G.J.; Lunt, S.Y.; Grunewald, T.G.P.; Park, M.; Rheenen, J. van & Fendt, S.M. (2022), PHGDH heterogeneity potentiates cancer cell dissemination and metastasis, Nature 605(7911): 747-+.
- Meeuwsen, M.H.; Wouters, A.K.; Hagedoorn, R.S.; Kester, M.G.D.; Remst, D.F.G.; Steen, D.M. van der; Ru, A. de; Veelen, P.A. van; Rossjohn, J.; Gras, S.; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2022), Cutting Edge: Unconventional CD8+ T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope, The Journal of Immunology 208(8): 1851-1856.
- Harryvan, T.J.; Visser, M.; Bruin, L. de; Plug, L.; Griffioen, L.; Mulder, A.; Veelen, P.A. van; Noort, G.J.V. van; Jongsma, M.L.; Meeuwsen, M.H.; Wiertz, E.J.; Santegoets, S.J.; Hardwick, J.C.; Hall, T. van; Neefjes, J.; Burg, S.H. van der; Hawinkels, L.J.A.C. & Verdegaal, E.M.E. (2022), Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S, Journal for ImmunoTherapy of Cancer 10(3).
- Hensbergen, P.J.; Ru, A.H. de; Friggen, A.H.; Corver, J.; Smits, W.K. & Veelen, P.A. van (2022), New insights into the type A glycan modification of Clostridioides difficile flagellar protein flagellin C by phosphoproteomics analysis, Journal of Biological Chemistry 298(3).
- Smits, W.K.; Mohammed, Y.; Ru, A.H. de; Cordo', V.; Friggen, A.H.; Veelen, P.A. van & Hensbergen, P.J. (2022), Clostridioides difficile phosphoproteomics shows an expansion of phosphorylated proteins in stationary growth phase, mSphere 7(1).
- Laghmouchi, A.; Kester, M.G.D.; Hoogstraten, C.; Hageman, L.; Klerk, W. de; Huisman, W.; Koster, E.A.S.; Ru, A.H. de; Balen, P. van; Klobuch, S.; Veelen, P.A. van; Falkenburg, J.H.F. & Jedema, I. (2022), Promiscuity of peptides presented in HLA-DP molecules from different immunogenicity groups is associated with T-cell cross-reactivity, Frontiers in Immunology 13.
- Meeuwsen, M.H.; Wouters, A.K.; Jahn, L.; Hagedoorn, R.S.; Kester, M.G.D.; Remst, D.F.G.; Morton, L.T.; Steen, D.M. van der; Kweekel, C.; Ru, A.H. de; Griffioen, M.; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2022), A broad and systematic approach to identify B cell malignancy-targeting TCRs for multi-antigen-based T cell therapy, Molecular Therapy 30(2): 564-578.
- Ali, M.; Giannakopoulou, E.; Li, Y.Q.; Lehander, M.; Culleton, S.V.; Yang, W.W.; Knetter, C.; Odabasi, M.C.; Bollineni, R.C.; Yang, X.B.; Foldvari, Z.; Boschen, M.L.; Taraldsrud, E.; Stronen, E.; Toebes, M.; Hillen, A.; Mazzi, S.; Ru, A.H. de; Janssen, G.M.C.; Kolstad, A.; Tjonnfjord, G.E.; Lie, B.A.; Griffioen, M.; Lehmann, S.; Osnes, L.T.; Buechner, J.; Garcia, K.C.; Schumacher, T.N.; Veelen, P.A. van; Leisegang, M.; Jacobsen, S.E.W.; Woll, P. & Olweus, J. (2021), T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes, Nature Biotechnology 40.
- Cordeiro, Y.G.; Mulder, L.M.; Zeijl, R.J.M. van; Paskoski, L.B.; Veelen, P. van; Ru, A. de; Strefezzi, R.F.; Heijs, B. & Fukumasu, H. (2021), Proteomic analysis identifies FNDC1, A1BG, and antigen processing proteins associated with tumor heterogeneity and malignancy in a canine model of breast cancer, Cancers 13(23).
- Stavast, C.J.; Zuijen, I. van; Karkoulia, E.; Ozcelik, A.; Hoven-Beijen, A. van; Leon, L.G.; Voerman, J.S.A.; Janssen, G.M.C.; Veelen, P.A. van; Burocziova, M.; Brouwer, R.W.W.; IJcken, W.F.J. van; Maas, A.; Bindels, E.M.; Velden, V.H.J. van der; Schliehe, C.; Katsikis, P.D.; Alberich-Jorda, M. & Erkeland, S.J. (2021), The tumor suppressor MIR139 is silenced by POLR2M to promote AML oncogenesis, Leukemia 36.
- Lee, D.I. van der; Koutsoumpli, G.; Reijmers, R.M.; Honders, M.W.; Jong, R.C.M. de; Remst, D.F.G.; Wachsmann, T.L.A.; Hagedoorn, R.S.; Franken, K.L.M.C.; Kester, M.G.D.; Harber, K.J.; Roelofsen, L.M.; Schouten, A.M.; Mulder, A.; Drijfhout, J.W.; Veelken, H.; Veelen, P.A. van; Heemskerk, M.H.M.; Falkenburg, J.H.F. & Griffioen, M. (2021), An HLA-A*11:01-binding neoantigen from mutated NPM1 as target for TCR gene therapy in AML, Cancers 13(21).
- Kollenstart, L.; Horst, S.C. van der; Vreeken, K.; Janssen, G.M.C.; Martino, F.; Vlaming, H.; Veelen, P.A. van; Leeuwen, F. van & Attikum, H. van (2021), Epigenetics Identifier screens reveal regulators of chromatin acylation and limited specificity of acylation antibodies, Scientific Reports 11(1).
- Uribe, M.L.; Martin-Nieto, J.; Quereda, C.; Rubio-Fernandez, M.; Cruces, J.; Janssen, G.M.C.; Ru, A.H. de; Veelen, P.A. van & Hensbergen, P.J. (2021), Retinal proteomics of a mouse model of dystroglycanopathies reveals molecular alterations in photoreceptors, Journal of Proteome Research 20(6): 3268-3277.
- Leeuwen, T. van; Araman, C.; Pournara, L.P.; Kampstra, A.S.B.; Bakkum, T.; Marqvorsen, M.H.S.; Nascimento, C.R.; Groenewold, G.J.M.; Wulp, W. van der; Camps, M.G.M.; Janssen, G.M.C.; Veelen, P.A. van; Westen, G.J.P. van; Janssen, A.P.A.; Florea, B.I.; Overkleeft, H.S.; Ossendorp, F.A.; Toes, R.E.M. & Kasteren, S.I. van (2021), Bioorthogonal protein labelling enables the study of antigen processing of citrullinated and carbamylated auto-antigens, RSC Chemical Biology 2(3): 855-862.
- Mons, E.; Kim, R.Q.; Doodewaerd, B.R. van; Veelen, P.A. van; Mulder, M.P.C. & Ovaa, H. (2021), Exploring the versatility of the covalent thiol-alkyne reaction with substituted propargyl warheads, Journal of the American Chemical Society 143(17): 6423-6433.
- Duarte, H.O.; Rodrigues, J.G.; Gomes, C.; Hensbergen, P.J.; Ederveen, A.L.H.; Ru, A.H. de; Mereiter, S.; Polonia, A.; Fernandes, E.; Ferreira, J.A.; Veelen, P.A. van; Santos, L.L.; Wuhrer, M.; Gomes, J. & Reis, C.A. (2021), ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab, Oncogene 40(21): 3719-3733.
- Verheul, M.K.; Janssen, G.M.C.; Ru, A. de; Stoeken-Rijsbergen, G.; Levarht, E.W.N.; Kwekkeboom, J.C.; Bomer, N.; Ioan-Facsinay, A.; Meulenbelt, I.; Cordfunke, R.A.; Drijfhout, J.W.; Toes, R.E.M.; Veelen, P.A. van & Trouw, L.A. (2021), Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls, Clinical and Experimental Rheumatology 39(3): 570-577.
- Pirro, M.; Mohammed, Y.; Ru, A.H. de; Janssen, G.M.C.; Tjokrodirijo, R.T.N.; Madunic, K.; Wuhrer, M.; Veelen, P.A. van & Hensbergen, P.J. (2021), Oxonium ion guided analysis of quantitative proteomics data reveals site-specific O-glycosylation of anterior gradient protein 2 (AGR2), International Journal of Molecular Sciences 22(10).
- Rodrigues, J.G.; Duarte, H.O.; Gomes, C.; Balmana, M.; Martins, A.M.; Hensbergen, P.J.; Ru, A.H. de; Lima, J.; Albergaria, A.; Veelen, P.A. van; Wuhrer, M.; Gomes, J. & Reis, C.A. (2021), Terminal alpha 2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells, Cellular Oncology 44(4): 835-850.
- Venema, W.J.; Hiddingh, S.; Boer, J.H. de; Claas, F.H.J.; Mulder, A.; Hollander, A.I. den; Stratikos, E.; Sarkizova, S.; Veken, L.T. van der; Janssen, G.M.C.; Veelen, P.A. van & Kuiper, J.J.W. (2021), ERAP2 increases the abundance of a peptide submotif highly selective for the Birdshot Uveitis-associated HLA-A29, Frontiers in Immunology 12.
- Waard, A.A. de; Verkerk, T.; Hoefakker, K.; Steen, D.M. van der; Jongsma, M.L.M.; Kadosh, D.M.; Bliss, S.; Ru, A.H. de; Admon, A.; Veelen, P.A. van; Griffioen, M.; Heemskerk, M.H.M. & Spaapen, R.M. (2021), Healthy cells functionally present TAP-independent SSR1 peptides, iScience 24(2).
- Meurer, T.; Crivello, P.; Metzing, M.; Kester, M.; Megger, D.A.; Chen, W.Q.; Veelen, P.A. van; Balen, P. van; Westendorf, A.M.; Homa, G.; Layer, S.E.; Turki, A.T.; Griffioen, M.; Horn, P.A.; Sitek, B.; Beelen, D.W.; Falkenburg, J.H.F.; Arrieta-Bolanos, E. & Fleischhauer, K. (2021), Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM, Blood 137(7): 923-928.
- Lippold, S.; Knaupp, A.; Ru, A.H. de; Tjokrodirijo, R.T.N.; Veelen, P.A. van; Puijenbroek, E. van; Taeye, S.W. de; Reusch, D.; Vidarsson, G.; Wuhrer, M.; Schlothauer, T. & Falck, D. (2021), Fc gamma receptor IIIb binding of individual antibody proteoforms resolved by affinity chromatography-mass spectrometry, mAbs 13(1).
- Lippold, S.; Ru, A.H. de; Nouta, J.; Veelen, P.A. van; Palmblad, M.; Wuhrer, M. & Haan, N. de (2020), Semiautomated glycoproteomics data analysis workflow for maximized glycopeptide identification and reliable quantification, Beilstein Journal of Organic Chemistry 16: 3038-3051.
- Cabukusta, B.; Berlin, I.; Elsland, D.M. van; Forkink, I.; Spits, M.; Jong, A.W.M. de; Akkermans, J.J.L.L.; Wijdeven, R.H.M.; Janssen, G.M.C.; Veelen, P.A. van & Neefjes, J. (2020), Human VAPome analysis reveals MOSPD1 and MOSPD3 as membrane contact site proteins interacting with FFAT-related FFNT motifs, Cell Reports 33(10).
- Wojcik, I.; Senard, T.; Graaf, E.L. de; Janssen, G.M.C.; Ru, A.H. de; Mohammed, Y.; Veelen, P.A. van; Vidarsson, G.; Wuhrer, M. & Falck, D. (2020), Site-specific glycosylation mapping of Fc gamma receptor IIIb from neutrophils of individual healthy donors, Analytical Chemistry 92(19): 13172-13181.
- Kooij, R.; Liu, S.H.; Sapmaz, A.; Xin, B.T.; Janssen, G.M.C.; Veelen, P.A. van; Ovaa, H.; Dijke, P. ten & Geurink, P.P. (2020), Small-molecule activity-based probe for monitoring ubiquitin C-terminal hydrolase L1 (UCHL1) activity in live cells and zebrafish embryos, Journal of the American Chemical Society 142(39): 16825-16841.
- Pirro, M.; Mohammed, Y.; Vliet, S.J. van; Rombouts, Y.; Sciacca, A.; Ru, A.H. de; Janssen, G.M.C.; Tjokrodirijo, R.T.N.; Wuhrer, M.; Veelen, P.A. van & Hensbergen, P.J. (2020), N-Glycoproteins have a major role in MGL binding to colorectal cancer cell lines, International Journal of Molecular Sciences 21(15).
- Hiller, M.; Geissler, M.; Janssen, G.; Veelen, P. van; Aartsma-Rus, A. & Spitali, P. (2020), The mRNA Binding Proteome of Proliferating and Differentiated Muscle Cells, GENOMICS PROTEOMICS & BIOINFORMATICS 18(4): 384-396.
- Balen, P. van; Kester, M.G.D.; Klerk, W. de; Crivello, P.; Arrieta-Bolanos, E.; Ru, A.H. de; Jedema, I.; Mohammed, Y.; Heemskerk, M.H.M.; Fleischhauer, K.; Veelen, P.A. van & Falkenburg, J.H.F. (2020), Immunopeptidome analysis of HLA-DPB1 allelic variants reveals new functional hierarchies, The Journal of Immunology 204(12): 3273-3282.
- Groot, N.G. de; Heijmans, C.M.C.; Ru, A.H. de; Otting, N.; Koning, F.; Veelen, P.A. van & Bontrop, R.E. (2020), The HLA A03 supertype and several pan species major histocompatibility complex class I A allotypes share a preference for binding positively charged residues in the F pocket, Journal of Virology 94(9).
- Kissel, T.; Reijm, S.; Slot, L.M.; Cavallari, M.; Wortel, C.M.; Vergroesen, R.D.; Stoeken-Rijsbergen, G.; Kwekkeboom, J.C.; Kampstra, A.S.B.; Levarht, E.W.N.; Drijfhout, J.W.; Bang, H.; Bonger, K.M.; Janssen, G.M.C.; Veelen, P.A. van; Huizinga, T.W.J.; Scherer, H.U.; Reth, M. & Toes, R.E.M. (2020), Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications, Annals of the Rheumatic Diseases 79(4): 472-480.
- Pirro, M.; Rombouts, Y.; Stella, A.; Neyrolles, O.; Burlet-Schiltz, O.; Vliet, S.J. van; Ru, A.H. de; Mohammed, Y.; Wuhrer, M.; Veelen, P.A. van & Hensbergen, P.J. (2020), Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines, BBA - General Subjects 1864(4).
- Momcilovic, A.; Haan, N. de; Ederveen, A.L.H.; Bondt, A.; Koeleman, C.A.M.; Falck, D.; Neef, L.A. de; Mesker, W.E.; Tollenaar, R.; Ru, A. de; Veelen, P. van; Wuhrer, M. & Dotz, V. (2020), Simultaneous immunoglobulin A and G glycopeptide profiling for high-throughput applications, Analytical Chemistry 92(6): 4518-4526.
- Smith, A.; Iablokov, V.; Mazza, M.; Guarnerio, S.; Denti, V.; Ivanova, M.; Stella, M.; Piga, I.; Chinello, C.; Heijs, B.; Veelen, P.A. van; Benediktsson, H.; Muruve, D.A. & Magni, F. (2020), Detecting proteomic indicators to distinguish diabetic nephropathy from hypertensive nephrosclerosis by integrating matrix-assisted laser desorption/ionization mass spectrometry imaging with high-mass accuracy mass spectrometry, Kidney and Blood Pressure Research 45(2): 233-248.
- Kemps, P.G.; Zondag, T.C.; Steenwijk, E.C.; Andriessen, Q.; Borst, J.; Vloemans, S.; Roelen, D.L.; Voortman, L.M.; Verdijk, R.M.; Noesel, C.J.M. van; Cleven, A.H.G.; Hawkins, C.; Lang, V.; Ru, A.H. de; Janssen, G.M.C.; Haasnoot, G.W.; Franken, K.L.M.C.; Eijk, R. van; Solleveld-Westerink, N.; Wezel, T. van; Egeler, R.M.; Beishuizen, A.; Laar, J.A.M. van; Abla, O.; Bos, C. van den; Veelen, P.A. van & Halteren, A.G.S. van (2020), Apparent lack of BRAF(V600E) derived HLA class I presented neoantigens hampers neoplastic cell targeting by CD8(+) T cells in langerhans cell histiocytosis, Frontiers in Immunology 10.
- Lubbers, R.; Oostindie, S.C.; Dijkstra, D.J.; Parren, P.W.H.I.; Verheul, M.K.; Abendstein, L.; Sharp, T.H.; Ru, A. de; Janssen, G.M.C.; Veelen, P.A. van; Bremer, E.T.J. van den; Bleijlevens, B.; Kreuk, B.J. de; Beurskens, F.J. & Trouw, L.A. (2020), Carbamylation reduces the capacity of IgG for hexamerization and complement activation, Clinical and Experimental Immunology 200(1).
- Hos, B.J.; Camps, M.G.M.; Bulk, J. van den; Tondini, E.; Ende, T.C. van den; Ruano, D.; Franken, K.; Janssen, G.M.C.; Ru, A.; Filippov, D.V.; Arens, R.; Veelen, P.A. van; Miranda, N. & Ossendorp, F. (2020), Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer, OncoImmunology 9(1).
- Gstottner, C.; Reusch, D.; Haberger, M.; Dragan, I.; Veelen, P. van; Kilgour, D.P.A.; Tsybin, Y.O.; Burgt, Y.E.M. van der; Wuhrer, M. & Nicolardi, S. (2020), Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry, mAbs 12(1): 1682403.
- Kollenstart, L.; Groot, A.J.L. de; Janssen, G.M.C.; Cheng, X.; Vreeken, K.; Martino, F.; Cote, J.; Veelen, P.A. van & Attikum, H. van (2019), Gcn5 and Esa1 function as histone crotonyltransferases to regulate crotonylation-dependent transcription, Journal of Biological Chemistry 294(52): 20122-20134.
- Kollenstart, L.; Groot, A.J.L. de; Janssen, G.M.C.; Cheng, X.; Vreeken, K.; Martino, F.; Cote, J.; Veelen, P.A. van & Attikum, H. van (2019), Gcn5 and Esa1 function as histone crotonyltransferases to regulate crotonylation-dependent transcription, Journal of Biological Chemistry 294(52): 20122-20134.
- Gjonaj, L.; Sapmaz, A.; Flierman, D.; Janssen, G.M.C.; Veelen, P.A. van & Ovaa, H. (2019), Development of a DUB-selective fluorogenic substrate, Chemical Science 10(44): 10290-10296.
- Kampstra, A.S.B.; Heemst, J. van; Janssen, G.M.; Ru, A.H. de; Lummel, M. van; Veelen, P.A. van & Toes, R.E.M. (2019), Ligandomes obtained from different HLA-class II-molecules are homologous for N- and C-terminal residues outside the peptide-binding cleft, Immunogenetics 71(8-9): 519-530.
- Kampstra, A.S.B.; Dekkers, J.S.; Volkov, M.; Dorjee, A.L.; Hafkenscheid, L.; Kempers, A.C.; Delft, M. van; Kissel, T.; Reijm, S.; Janssen, G.M.C.; Veelen, P.A. van; Bang, H.; Huizinga, T.W.J.; Trouw, L.A.; Woude, D. van der & Toes, R.E.M. (2019), Different classes of anti-modified protein antibodies are induced on exposure to antigens expressing only one type of modification, Annals of the Rheumatic Diseases 78(7): 908-916.
- Lummel, M. van; Buis, D.T.P.; Ringeling, C.; Ru, A.H. de; Pool, J.; Papadopoulos, G.K.; Veelen, P.A. van; Reijonen, H.; Drijfhout, J.W. & Roep, B.O. (2019), Epitope Stealing as a Mechanism of Dominant Protection by HLA-DQ6 in Type 1 Diabetes, Diabetes 68(4): 787-795.
- Pirro, M.; Schoof, E.; Vliet, S.J. van; Rombouts, Y.; Stella, A.; Ru, A. de; Mohammed, Y.; Wuhrer, M.; Veelen, P.A. van & Hensbergen, P.J. (2019), Glycoproteomic Analysis of MGL-Binding Proteins on Acute T-Cell Leukemia Cells, Journal of Proteome Research 18(3).
- Mons, E.; Jansen, I.D.C.; Loboda, J.; Doodewaerd, B.R. van; Hermans, J.; Verdoes, M.; Boeckel, C.A.A. van; Veelen, P.A. van; Turk, B.; Turk, D. & Ovaa, H. (2019), The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K, Journal of the American Chemical Society 141(8): 3507-3514.
- Lee, D.I. van der; Reijmers, R.M.; Honders, M.W.; Hagedoorn, R.S.; Jong, R.C.M. de; Kester, M.G.D.; Steen, D.M. van der; Ru, A.H. de; Kweekel, C.; Bijen, H.M.; Jedema, I.; Veelken, H.; Veelen, P.A. van; Heemskerk, M.H.M.; Falkenburg, J.H.F. & Griffioen, M. (2019), Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemia, Journal of Clinical Investigation 129(2): 774-785.
- Benne, N.; Duijn, J. van; Vigario, F.L.; Leboux, R.J.T.; Veelen, P. van; Kuiper, J.; Jiskoot, W. & Stutter, B. (2018), Anionic 1,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice, Journal of Controlled Release 291: 135-146.
- Balen, P. van; Kester, M.G.D.; Crivello, P.; Ru, A.H. de; Klerk, W. de; Meent, M. van de; Jedema, I.; Fleischhauer, K.; Falkenburg, J.H.F. & Veelen, P.A. van (2018), Motifs of peptides binding in HLA-DP and their relation with T-cell epitope groups relevant in stem cell transplantation, Bone Marrow Transplantation 53: 64-65.
- Klychnikov, O.I.; Shamorkina, T.M.; Weeks, S.D.; Leeuwen, H.C. van; Corver, J.; Drijfhout, J.W.; Veelen, P.A. van; Sluchanko, N.N.; Strelkov, S.V. & Hensbergen, P.J. (2018), Discovery of a new Pro-Pro endopeptidase, PPEP-2, provides mechanistic insights into the differences in substrate specificity within the PPEP family, Journal of Biological Chemistry 293(28): 11154-11165.
- Lill, J.R.; Veelen, P.A. van; Tenzer, S.; Admon, A.; Caron, E.; Elias, J.E.; Heck, A.J.R.; Marcilla, M.; Marino, F.; Muller, M.; Peters, B.; Purcell, A.; Sette, A.; Sturm, T.; Ternette, N.; Vizcaino, J.A. & Bassani-Sternberg, M. (2018), Minimal Information About an Immuno-Peptidomics Experiment (MIAIPE), Proteomics 18(12).
- Bijen, H.M.; Hassan, C.; Kester, M.G.D.; Janssen, G.M.C.; Hombrink, P.; Ru, A.H. de; Drijfhout, J.W.; Meiring, H.D.; Jong, A.P. de; Falkenburg, J.H.F.; Jimenez, C.R.; Heemskerk, M.H.M. & Veelen, P.A. van (2018), Specific TCell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface, Proteomics 18(12).
- Luimstra, J.J.; Garstka, M.A.; Roex, M.C.J.; Redeker, A.; Janssen, G.M.C.; Veelen, P.A. van; Arens, R.; Falkenburg, J.H.F.; Neefjes, J. & Ovaa, H. (2018), A flexible MHC class I multimer loading system for large-scale detection of antigen-specific T cells, Journal of Experimental Medicine 215(5): 1493-1504.
- Kronenberg-Versteeg, D.; Eichmann, M.; Russell, M.A.; Ru, A. de; Hehn, B.; Yusuf, N.; Veelen, P.A. van; Richardson, S.J.; Morgan, N.G.; Lemberg, M.K. & Peakman, M. (2018), Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 Diabetes, Diabetes 67(4): 687-696.
- Verheul, M.K.; Veelen, P.A. van; Delft, M.A.M. van; Ru, A. de; Janssen, G.M.C.; Rispens, T.; Toes, R.E.M. & Trouw, L.A. (2018), Pitfalls in the detection of citrullination and carbamylation, Autoimmunity Reviews 17(2): 136-141.
- Shao, W.G.; Pedrioli, P.G.A.; Wolski, W.; Scurtescu, C.; Schmid, E.; Vizcaino, J.A.; Courcelles, M.; Schuster, H.; Kowalewski, D.; Marino, F.; Arlehamn, C.S.L.; Vaughan, K.; Peters, B.; Sette, A.; Ottenhoff, T.H.M.; Meijgaarden, K.E.; Nieuwenhuizen, N.; Kaufmann, S.H.E.; Schlapbach, R.; Castle, J.C.; Nesvizhskii, A.I.; Nielsen, M.; Deutsch, E.W.; Campbell, D.S.; Moritz, R.L.; Zubarev, R.A.; Ytterberg, A.J.; Purcell, A.W.; Marcilla, M.; Paradela, A.; Wang, Q.; Costello, C.E.; Ternette, N.; Veelen, P.A. van; Els, C.A.C.M. van; Heck, A.J.R.; Souza, G.A. de; Sollid, L.M.; Admon, A.; Stevanovic, S.; Rammensee, H.G.; Thibault, P.; Perreault, C.; Bassani-Sternberg, M.; Aebersold, R. & Caron, E. (2018), The SysteMHC Atlas project, Nucleic Acids Research 46(D1): D1237-D1247.
- Groot, N.G. de; Heijmans, C.M.C.; Ru, A.H. de; Janssen, G.M.C.; Drijfhout, J.W.; Otting, N.; Vangenot, C.; Doxiadis, G.G.M.; Koning, F.; Veelen, P.A. van & Bontrop, R.E. (2017), A Specialist Macaque MHC Class I Molecule with HLA-B*27-like Peptide-Binding Characteristics, Journal of Immunology 199(10): 3679-3690.
- Groot, N.G. de; Heijmans, C.M.C.; Ru, A.H. de; Janssen, G.M.C.; Drijfhout, J.W.; Otting, N.; Vangenot, C.; Doxiadis, G.G.M.; Koning, F.; Veelen, P.A. van & Bontrop, R.E. (2017), A Specialist Macaque MHC Class I Molecule with HLA-B*27-like Peptide-Binding Characteristics, Journal of Immunology 199(10): 3679-3690.
- Dekkers, J.S.; Verheul, M.K.; Stoop, J.N.; Liu, B.S.; Ioan-Facsinay, A.; Veelen, P.A. van; Ru, A.H. de; Janssen, G.M.C.; Hegen, M.; Rapecki, S.; Huizinga, T.W.J.; Trouw, L.A. & Toes, R.E.M. (2017), Breach of autoreactive B cell tolerance by post-translationally modified proteins, Annals of the Rheumatic Diseases 76(8): 1449-1457.
- Zhou, L.; Kooy-Winkelaar, Y.M.C.; Cordfunke, R.A.; Dragan, I.; Thompson, A.; Drijthou, J.W.; Veelen, P.A. van; Chen, H.B. & Koning, F. (2017), Abrogation of Immunogenic Properties of Gliadin Peptides through Transamidation by Microbial Transglutaminase Is Acyl-Acceptor Dependent, Journal of Agricultural and Food Chemistry 65(34): 7542-7552.
- Dekkers, J.; Verheul, M.; Stoop, J.; Liu, B.; Ioan-Facsinay, A.; Veelen, P. van; Ru, A. de; Janssen, G.; Hegen, M.; Rapecki, S.; Huizinga, T.; Trouw, L. & Toes, R. (2017), BREACH OF AUTOREACTIVE B-CELL TOLERANCE BY, Annals of the Rheumatic Diseases 76: 778-779.
- Verheul, M.K.; Yee, A.; Seaman, A.; Janssen, G.M.; Veelen, P.A. van; Drijfhout, J.W.; Toes, R.E.M.; Mahler, M. & Trouw, L.A. (2017), Identification of carbamylated alpha 1 anti-trypsin (A1AT) as an antigenic target of anti-CarP antibodies in patients with rheumatoid arthritis, Journal of Autoimmunity 80: 77-84.
- Groot, N.G. de; Heijmans, C.M.C.; Ru, A.H. de; Janssen, G.M.C.; Drijfhout, J.W.; Otting, N.; Vangenot, C.; Doxiadis, G.G.M.; Koning, F.; Veelen, P.A. van & Bontrop, R.E. (2017), THE MACAQUE A2*05 GENE ENCODES FOR SPECIALIST MHC MOLECULES WITH HLA-B*27-LIKE PEPTIDE-BINDING CHARACTERISTICS, Hla 89(6): 356-357.
- Kracht, M.J.L.; Lummel, M. van; Nikolic, T.; Joosten, A.M.; Laban, S.; Slik, A.R. van der; Veelen, P.A. van; Carlotti, F.; Koning, E.J.P. de; Hoeben, R.C.; Zaldumbide, A. & Roep, B.O. (2017), Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes, Nature Medicine 23(4): 501-+.
- Jahn, L.; Hombrink, P.; Hagedoorn, R.S.; Kester, M.G.D.; Steen, D.M. van der; Rodriguez, T.; Pentcheva-Hoang, T.; Ru, A.H.; Schoonakker, M.P.; Meeuwsen, M.H.; Griffioen, M.; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2017), TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1, Blood 129(10): 1284-1295.
- Kooy-Winkelaar, Y.M.C.; Bouwer, D.; Janssen, G.M.C.; Thompson, A.; Brugman, M.H.; Schmitz, F.; Ru, A.H. de; Gils, T. van; Bouma, G.; Rood, J.J. van; Veelen, P.A. van; Mearin, M.L.; Mulder, C.J.; Koning, F. & Bergen, J. van (2017), CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes, Proceedings of the National Academy of Sciences 114(6): E980-E989.
- Keijzer, J. de; Mulder, A.; Ru, A.H. de; Soolingen, D. van & Veelen, P.A. van (2017), Parallel reaction monitoring of clinical Mycobacterium tuberculosis lineages reveals pre-existent markers of rifampicin tolerance in the emerging Beijing lineage, Journal of Proteomics 150: 9-17.
- Dekkers, J.S.; Verheul, M.K.; Stoop, J.N.; Liu, B.S.; Ioan-Facsinay, A.; Veelen, P.A. van; Ru, A.H. de; Janssen, G.M.C.; Hegen, M.; Rapecki, S.; Huizinga, T.W.J.; Trouw, L.A. & Toes, R.E.M. (2017), Breach of autoreactive B-cell tolerance by post-translationally modified foreign proteins, Annals of the Rheumatic Diseases.
- Bergen, C.A.M. van; Steen, D.M. van der; Kester, M.G.D.; Koning, M.T.; Veelen, P.A. van; Griffioen, M.; Falkenburg, J.H.F.; Heemskerk, M.H.M.; Veelken, H. & Navarrete, M.A. (2016), Endogenous Immunoglobulin-Derived Neoepitopes Are Processed and Form a Sizeable Fraction of the HLA Class I Ligandome of Human Lymphoma Cells, Blood 128(22).
- Jahn, L.; Steen, D.M. van der; Hagedoorn, R.S.; Hombrink, P.; Kester, M.G.D.; Schoonakker, M.P.; Ridder, D. de; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2016), Generation of CD20-specific TCRs for TCR gene therapy of CD20(low) B-cell malignancies insusceptible to CD20-targeting antibodies, Oncotarget 7(47): 77021-77037.
- Jahn, L.; Hagedoorn, R.S.; Steen, D.M. van der; Hombrink, P.; Kester, M.G.D.; Schoonakker, M.P.; Ridder, D. de; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2016), A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer, Oncotarget 7(44): 71536-71547.
- Dekkers, J.; Verheul, M.K.; Stoop, J.; Liu, B.; Veelen, P.A. van; Hegen, M.; Rapecki, S.; Huizinga, T.W.J.; Trouw, L.A. & Toes, R. (2016), Exposure to Carbamylated Self- and Non-Self-Proteins Can Lead to a Break-of -Tolerance and the Induction of Autoimmunity, Arthritis and Rheumatology 68.
- Nejad, E.B.; Sluis, T.C. van der; Duikeren, S. van; Yagita, H.; Janssen, G.M.; Veelen, P.A. van; Melief, C.J.M.; Burg, S.H. van der & Arens, R. (2016), Tumor Eradication by Cisplatin Is Sustained by CD80/86-Mediated Costimulation of CD8(+) T Cells, Cancer Research 76(20): 6017-6029.
- Wojtowicz, E.E.; Lechman, E.R.; Hermans, K.G.; Schoof, E.M.; Wienholds, E.; Isserlin, R.; Veelen, P.A. van; Broekhuis, M.J.C.; Janssen, G.M.C.; Trotman-Grant, A.; Dobson, S.M.; Krivdova, G.; Elzinga, J.; Kennedy, J.; Gan, O.I.; Sinha, A.; Ignatchenko, V.; Kislinger, T.; Dethmers-Ausema, B.; Weersing, E.; Alemdehy, M.F.; Looper, H.W.J. de; Bader, G.D.; Ritsema, M.; Erkeland, S.J.; Bystrykh, L.V.; Dick, J.E. & Haan, G. de (2016), Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors, Cell Stem Cell 19(3): 383-396.
- McLaughlin, R.J.; Haan, A. de; Zaldumbide, A.; Koning, E.J. de; Ru, A.H. de; Veelen, P.A. van; Lummel, M. van & Roep, B.O. (2016), Human islets and dendritic cells generate post-translationally modified islet autoantigens, Clinical and Experimental Immunology 185(2): 133-140.
- Heijs, B.; Holst, S.; Briaire-de Bruijn, I.H.; Pelt, G.W. van; Ru, A.H. de; Veelen, P.A. van; Drake, R.R.; Mehta, A.S.; Mesker, W.E.; Tollenaar, R.A.; Bovee, J.V.M.G.; Wuhrer, M. & McDonnell, L.A. (2016), Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section, Analytical Chemistry 88(15): 7745-7753.
- Jongsma, M.L.M.; Berlin, I.; Wijdeven, R.H.M.; Janssen, L.; Janssen, G.M.C.; Garstka, M.A.; Janssen, H.; Mensink, M.; Veelen, P.A. van; Spaapen, R.M. & Neefjes, J. (2016), An ER-Associated Pathway Defines Endosomal Architecture for Controlled Cargo Transport, Cell 166(1): 152-166.
- Keijzer, J. de; Mulder, A.; Haas, P.E.W. de; Ru, A.H. de; Heerkens, E.M.; Amaral, L.; Soolingen, D. van & Veelen, P.A. van (2016), Thioridazine Alters the Cell-Envelope Permeability of Mycobacterium tuberculosis, Journal of Proteome Research 15(6): 1776-1786.
- Keijzer, J. de; Mulder, A.; Beer, J. de; Ru, A.H. de; Veelen, P.A. van & Soolingen, D. van (2016), Mechanisms of Phenotypic Rifampicin Tolerance in Mycobacterium tuberculosis Beijing Genotype Strain B0/W148 Revealed by Proteomics, Journal of Proteome Research 15(4): 1194-1204.
- Lummel, M. van; Veelen, P.A. van; Ru, A.H. de; Janssen, G.M.C.; Pool, J.; Laban, S.; Joosten, A.M.; Nikolic, T.; Drijfhout, J.W.; Mearin, M.L.; Aanstoot, H.J.; Peakman, M. & Roep, B.O. (2016), Dendritic Cells Guide Islet Autoimmunity through a Restricted and Uniquely Processed Peptidome Presented by High-Risk HLA-DR, Journal of Immunology 196(8): 3253-3263.
- Lummel, M. van; Veelen, P.A. van; Ru, A.H. de; Pool, J.; Nikolic, T.; Laban, S.; Joosten, A.; Drijfhout, J.W.; Gomez-Tourino, I.; Arif, S.; Aanstoot, H.J.; Peakman, M. & Roep, B.O. (2016), Discovery of a Selective Islet Peptidome Presented by the Highest-Risk HLA-DQ8trans Molecule, Diabetes 65(3): 732-741.
- Rombouts, Y.; Willemze, A.; Beers, J.J.B.C. van; Shi, J.; Kerkman, P.F.; Toorn, L. van; Janssen, G.M.C.; Zaldumbide, A.; Hoeben, R.C.; Pruijn, G.J.M.; Deelder, A.M.; Wolbink, G.; Rispens, T.; Veelen, P.A. van; Huizinga, T.W.J.; Wuhrer, M.; Trouw, L.A.; Scherer, H.U. & Toes, R.E.M. (2016), Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis, Annals of the Rheumatic Diseases 75(3): 578-585.
- Plas-Duivesteijn, S.J. van der; Wulff, T.; Klychnikov, O.; Ohana, D.; Dalebout, H.; Veelen, P.A. van; Keijzer, J. de; Nessen, M.A.; Burgt, Y.E.M. van der; Deelder, A.M. & Palmblad, M. (2016), Differentiating samples and experimental protocols by direct comparison of tandem mass spectra, Rapid Communications in Mass Spectrometry 30(6): 731-738.
- Rombouts, Y.; Willemze, A.; Beers, J.J.B.C. van; Shi, J.; Kerkman, P.F.; Toorn, L. van; Janssen, G.M.C.; Zaldumbide, A.; Hoeben, R.C.; Pruijn, G.J.M.; Deelder, A.M.; Wolbink, G.; Rispens, T.; Veelen, P.A. van; Huizinga, T.W.J.; Wuhrer, M.; Trouw, L.A.; Scherer, H.U. & Toes, R.E.M. (2016), Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis, Annals of the Rheumatic Diseases 75(3): 578-585.
- Dekkers, J.S.; Verheul, M.K.; Stoop, J.N.; Veelen, P.A.; Janssen, G.M.C.; Huizinga, T.W.; Trouw, L.A. & Toes, R.E. (2016), CARBAMYLATED AUTOANTIGENS FACILITATE THE BREAK OF TOLERANCE: A NOVEL MECHANISM IN THE PATHOGENESIS OF AUTOIMMUNE ARTHRITIS, Annals of the Rheumatic Diseases 75: A17-A17.
- Spaapen, R.M.; Blomen, V.; Veelen, P.A. van; Jongsma, M.L.; Schrikkema, B.; Heijden, T. van der; Janssen, L.; Janssen, G.M.C.; Raaben, M.; Schumacher, T.; Brummelkamp, T.R. & Neefjes, J. (2015), Identification of novel essential regulators in the MHC class I network, Molecular Immunology 68(2): 143-143.
- Jahn, L.; Hagedoorn, R.S.; Hombrink, P.; Kester, M.G.D.; Steen, D.M. van der; Hassan, C.; Schoonakker, M.P.; Pijl, E. van der; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2015), Cell Receptor Gene Therapy Targeting the Intracellular Transcription Factor Bob1 for the Treatment of Multiple Myeloma and Other B Cell Malignancies, Blood 126(23).
- Verheul, M.K.; Yea, A.; Seaman, A.; Cordfunke, R.A.; Drijfhout, J.W.; Janssen, G.M.; Ru, A. de; Veelen, P.A. van; Toes, R.E.M.; Mahler, M. & Trouw, L.A. (2015), Identification of Carbamylated Alpha-1-Anti-Trypsin (A1AT) As an Antigenic Target of Anti-Carp Antibodies in Patients with Rheumatoid Arthritis, Arthritis and Rheumatology 67.
- Lehmann, K.C.; Gulyaeva, A.; Zevenhoven-Dobbe, J.C.; Janssen, G.M.C.; Ruben, M.; Overkleeft, H.S.; Veelen, P.A. van; Samborskiy, D.V.; Kravchenko, A.A.; Leontovich, A.M.; Sidorov, I.A.; Snijder, E.J.; Posthuma, C.C. & Gorbalenya, A.E. (2015), Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses, Nucleic Acids Research 43(17): 8416-8434.
- Treffers, E.E.; Tas, A.; Scholte, F.E.M.; , M.N. van; Heemskerk, M.T.; Ru, A.H. de; Snijder, E.J.; Hemert, M.J. van & Veelen, P.A. van (2015), Temporal SILAC-based quantitative proteomics identifies host factors involved in chikungunya virus replication, Proteomics 15(13): 2267-2280.
- Hoelen, H.; Zaldumbide, A.; Leeuwen, W.F. van; Torfs, E.C.W.; Engelse, M.A.; Hassan, C.; Lebbink, R.J.; Koning, E.J. de; Resssing, M.E.; Ru, A.H. de; Veelen, P.A. van; Hoeben, R.C.; Roep, B.O. & Wiertz, E.J.H.J. (2015), Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97, PLoS ONE 10(6).
- Alemdehy, M.F.; Haanstra, J.R.; Looper, H.W.J. de; Strien, P.M.H. van; Verhagen-Oldenampsen, J.; Caljouw, Y.; Sanders, M.A.; Hoogenboezem, R.; Ru, A.H. de; Janssen, G.M.C.; Smetsers, S.E.; Bierings, M.B.; Veelen, P.A. van; Lindern, M. von; Touw, I.P. & Erkeland, S.J. (2015), ICL-induced miR139-3p and miR199a-3p have opposite roles in hematopoietic cell expansion and leukemic transformation, Blood 125(25): 3937-3948.
- Janssen, G.; Christis, C.; Kooy-Winkelaar, Y.; Edens, L.; Smith, D.; Veelen, P. van & Koning, F. (2015), Ineffective Degradation of Immunogenic Gluten Epitopes by Currently Available Digestive Enzyme Supplements, PLoS ONE 10(6).
- Groot, N. de; Heijmans, C.M.C.; Ru, A.H. de; Janssen, G.M.C.; Drijfhout, J.W.; Otting, N.; Doxiadis, G.G.M.; Koning, F.; Veelen, P.A. van & Bontrop, R.E. (2015), MHC CLASS I MOLECULE WITH NON-CLASSICAL FEATURES HAS HLA-B*27-LIKE PEPTIDE-BINDING CHARACTERISTICS, Tissue Antigens 85(5): 309-309.
- Hombrink, P.; Hassan, C.; Kester, M.G.D.; Jahn, L.; Pont, M.J.; Ru, A.H. de; Bergen, C.A.M. van; Griffioen, M.; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2015), Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach, Clinical Cancer Research 21(9): 2177-2186.
- Jahn, L.; Hombrink, P.; Hassan, C.; Kester, M.G.D.; Steen, D.M. van der; Hagedoorn, R.S.; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2015), Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79b, Blood 125(6): 949-958.
- Heijs, B.; Carreira, R.J.; Tolner, E.A.; Ru, A.H. de; Maagdenberg, A.J.M. van den; Veelen, P.A. van & McDonnell, L.A. (2015), Comprehensive Analysis of the Mouse Brain Proteome Sampled in Mass Spectrometry Imaging, Analytical Chemistry 87(3): 1867-1875.
- Garstka, M.A.; Fish, A.; Celie, P.H.N.; Joosten, R.P.; Janssen, G.M.C.; Berlin, I.; Hoppes, R.; Stadnik, M.; Janssen, L.; Ovaa, H.; Veelen, P.A. van; Perrakis, A. & Neefjes, J. (2015), The first step of peptide selection in antigen presentation by MHC class I molecules, Proceedings of the National Academy of Sciences 112(5): 1505-1510.
- Hassan, C.; Chabrol, E.; Jahn, L.; Kester, M.G.D.; Ru, A.H. de; Drijfhout, J.W.; Rossjohn, J.; Falkenburg, J.H.F.; Heemskerk, M.H.M.; Gras, S. & Veelen, P.A. van (2015), Naturally Processed Non-canonical HLA-A*02:01 Presented Peptides, Journal of Biological Chemistry 290(5): 2593-2603.
- Jahn, L.; Hombrink, P.; Hassan, C.; Kester, M.G.D.; Hagedoorn, R.S.; Steen, D.M. van der; Schoonakker, M.P.; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2014), High-Affinity CD20-Specific T-Cell Receptors Suitable for Adoptive Immunotherapy in the Treatment of CD20(low) B-Cell Malignancies, Blood 124(21).
- Jahn, L.; Hombrink, P.; Kester, M.G.D.; Steen, D.M. van der; Hagedoorn, R.S.; Hassan, C.; Schoonakker, M.P.; Pijl, E. van der; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2014), T Cell Receptors Specific for the Intracellular Transcription Factor Bob1 Allow Efficient Targeting of Human B Cell Leukemia and Multiple Myeloma, Blood 124(21).
- Jahn, L.; Hombrink, P.; Hassan, C.; Kester, M.G.D.; Hagedoorn, R.S.; Schoonakker, M.P.; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2014), High-affinity CD20-specific TCRs suitable for adoptive immunotherapy in the treatment of CD20low B cell malignancies, Human Gene Therapy 25(11): A92-A92.
- Keijzer, J. de; Haas, P.E. de; Ru, A.H. de; Veelen, P.A. van & Soolingen, D. van (2014), Disclosure of Selective Advantages in the "modern" Sublineage of the Mycobacterium tuberculosis Beijing Genotype Family by Quantitative Proteomics, Molecular and Cellular Proteomics 13(10): 2632-2645.
- Eichmann, M.; Ru, A. de; Veelen, P.A. van; Peakman, M. & Kronenberg-Versteeg, D. (2014), Identification and characterisation of peptide binding motifs of six autoimmune disease-associated human leukocyte antigen-class I molecules including HLA-B*39:06, Tissue Antigens 84(4): 378-388.
- Hassan, C.; Kester, M.G.D.; Oudgenoeg, G.; Ru, A.H. de; Janssen, G.M.C.; Drijfhout, J.W.; Spaapen, R.M.; Jimenez, C.R.; Heemskerk, M.H.M.; Falkenburg, J.H.F. & Veelen, P.A. van (2014), Accurate quantitation of MHC-bound peptides by application of isotopically labeled peptide MHC complexes, Journal of Proteomics 109: 240-244.
- Scherer, H.U.; Rombouts, Y.; Willemze, A.; Beers, J. van; Shi, J.; Kerkman, P.; Janssen, G.; Veelen, P. van; Zaldumbide, A.; Hoeben, R.; Pruijn, G.; Deelder, A.; Wolbink, G.J.; Rispens, T.; Huizinga, T.W.; Wuhrer, M.; Trouw, L. & Toes, R. (2014), A HIGH FREQUENCY OF N-GLYCANS IN THE ACPA-IGG VARIABLE DOMAIN MODULATES REACTIVITY TO CITRULLINATED ANTIGENS, Annals of the Rheumatic Diseases 73: 129-129.
- Li, Y.H.; Treffers, E.E.; Napthine, S.; Tas, A.; Zhu, L.C.; Sun, Z.; Bell, S.; Mark, B.L.; Veelen, P.A. van; Hemert, M.J. van; Firth, A.E.; Brierley, I.; Snijder, E.J. & Fang, Y. (2014), Transactivation of programmed ribosomal frameshifting by a viral protein, Proceedings of the National Academy of Sciences 111(21): E2172-E2181.
- Assohou-Luty, C.; Raijmakers, R.; Benckhuijsen, W.E.; Stammen-Vogelzangs, J.; Ru, A. de; Veelen, P.A. van; Franken, K.L.M.C.; Drijfhout, J.W. & Pruijn, G.J.M. (2014), The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities, BBA - Proteins and Proteomics 1844(4): 829-836.
- Shi, J.; Veelen, P.A. van; Mahler, M.; Janssen, G.M.C.; Drijfhout, J.W.; Huizinga, T.W.J.; Toes, R.E.M. & Trouw, L.A. (2014), Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies, Autoimmunity Reviews 13(3): 225-230.
- Jahn, L.; Hombrink, P.; Kester, M.G.D.; Schoonakker, M.P.; Falkenburg, J.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2014), HIGH-AFFINITY CD20-SPECIFIC TCRS SUITABLE FOR ADOPTIVE IMMUNOTHERAPY CAN BE READILY ISOLATED FROM THE ALLO-REPERTOIRE USING REVERSE IMMUNOLOGY, Bone Marrow Transplantation 49: S17-S17.
- Lummel, M. van; Duinkerken, G.; Veelen, P.A. van; Ru, A. de; Cordfunke, R.; Zaldumbide, A.; Gomez-Tourino, I.; Arif, S.; Peakman, M.; Drijfhout, J.W. & Roep, B.O. (2014), Posttranslational Modification of HLA-DQ Binding Islet Autoantigens in Type 1 Diabetes, Diabetes 63(1): 237-247.
- Groot, N.G. de; Heijmans, C.M.C.; Ru, A.H. de; Hassan, C.; Otting, N.; Doxiadis, G.G.M.; Koning, F.; Veelen, P.A. van & Bontrop, R.E. (2013), Unique peptide-binding motif for Mamu-B*037:01: an MHC class I allele common to Indian and Chinese rhesus macaques, Immunogenetics 65(12): 897-900.
- Kooij, B. van de; Rooswinkel, R.W.; Kok, F.; Herrebout, M.; Vries, E. de; Paauwe, M.; Janssen, G.M.C.; Veelen, P.A. van & Borst, J. (2013), Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B, Oncogene 32(48): 5439-5448.
- Rosalia Rodney A., Quakkelaar Esther D., Redeker Anke, Khan Selina, Camps Marcel, Drijfhout Jan W., Silva Ana Luisa, Jiskoot Wim, Van Hall Thorbald, Van Veelen Peter A., Janssen George, Franken Kees, Cruz Luis J., Tromp Angelino, Oostendorp Jaap, Van derBurg Sjoerd H., Ossendorp Ferry & Melief Cornelis J.M. (2013), Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation, European Journal of Immunology 43(10): 2554-2565.
- Rosalia, R.A.; Quakkelaar, E.D.; Redeker, A.; Khan, S.; Camps, M.; Drijfhout, J.W.; Silva, A.L.; Jiskoot, W.; Hall, T. van; Veelen, P.A. van; Janssen, G.; Franken, K.; Cruz, L.J.; Tromp, A.; Oostendorp, J.; derBurg, S.H. van; Ossendorp, F. & Melief, C.J.M. (2013), Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation, European Journal of Immunology 43(10): 2554-2565.
- Haarlem, M.P. van; Wise, M.W.; Gunst, A.W.; Heald, G.; McKean, J.P.; Hessels, J.W.T.; Bruyn, A.G. de; Nijboer, R.; Swinbank, J.; Fallows, R.; Brentjens, M.; Nelles, A.; Beck, R.; Falcke, H.; Fender, R.; Horandel, J.; Koopmans, L.V.E.; Mann, G.; Miley, G.; Rottgering, H.; Stappers, B.W.; Wijers, R.A.M.J.; Zaroubi, S.; Akker, M. van den; Alexov, A.; Anderson, J.; Anderson, K.; Ardenne, A. van; Arts, M.; Asgekar, A.; Avruch, I.M.; Batejat, F.; Bahren, L.; Bell, M.E.; Bell, M.R.; Bemmel, I. van; Bennema, P.; Bentum, M.J.; Bernardi, G.; Best, P.; Birzan, L.; Bonafede, A.; Boonstra, A.J.; Braun, R.; Bregman, J.; Breitling, F.; Brink, R.H. van de; Broderick, J.; Broekema, P.C.; Brouw, W.N.; Bruggen, M.; Butcher, H.R.; Cappellen, W. van; Ciardi, B.; Coenen, T.; Conway, J.; Coolen, A.; Corstanje, A.; Damstra, S.; Davies, O.; Deller, A.T.; Dettmar, R.J.; Diepen, G. van; Dijkstra, K.; Donker, P.; Doorduin, A.; Dromer, J.; Drost, M.; Duin, A. van; Eisloffel, J.; Enst, J. van; Ferrari, C.; Frieswijk, W.; Gankema, H.; Garrett, M.A.; Gasparin, F. de; Gerbers, M.; Geus, E. de; Griessmeier, J.M.; Grit, T.; Gruppen, P.; Hamaker, J.P.; Hassall, T.; Hoeft, M.; Holties, H.A.; Horneffer, A.; Horst, A. van der; Houwelingen, A. van; Huijgen, A.; Iacobelli, M.; Intema, H.; Jackson, N.; Jelic, V.; Jong, A. de; Kant, D.; Karastergiou, A.; Koers, A.; Kollen, H.; Kondratiev, V.I.; Kooistra, E.; Koopman, Y.; Koster, A.; Kuniyoshi, M.; Kramer, M.; Kuper, G.; Lambropoulos, P.; Law, C.; Leeuwen, J. van; Lemaitre, J.; Loose, M.; Maat, P.; Macario, G.; Markoff, S.; Masters, J.; McFadden, R.A.; McKay-Bukowski, D.; Meijering, H.; Meulman, H.; Mevius, M.; Millenaar, R.; Miller-Jones, J.C.A.; Mohan, R.N.; Mol, J.D.; Morawietz, J.; Morganti, R.; Mulcahy, D.D.; Mulder, E.; Munk, H.; Nieuwenhuis, L.; Nieuwpoort, R. van; Noordam, J.E.; Norden, M.; Noutsos, A.; Offringa, A.R.; Olofsson, H.; Omar, A.; Orru, E.; Overeem, R.; Paas, H.; Pandey-Pommier, M.; Pandey, V.N.; Pizzo, R.; Polatidis, A.; Rafferty, D.; Rawlings, S.; Reich, W.; Reijer, J.P. de; Reitsma, J.; Renting, G.A.; Riemers, P.; Rol, E.; Romein, J.W.; Roosjen, J.; Ruiter, M.; Scaife, A.; Schaaf, K. van der; Scheers, B.; Schellart, P.; Schoenmakers, A.; Schoonderbeek, G.; Serylak, M.; Shulevski, A.; Sluman, J.; Smirnov, O.; Sobey, C.; Spreeuw, H.; Steinmetz, M.; Sterks, C.G.M.; Stiepel, H.J.; Stuurwold, K.; Tagger, M.; Tang, Y.; Tasse, C.; Thomas, I.; Thoudam, S.; Toribio, M.C.; Tol, B. van der; Usov, O.; Veelen, M. van; Veen, A.J. van der; Veen, S. ter; Verbiest, J.P.W.; Vermeulen, R.; Vermaas, N.; Vocks, C.; Vogt, C.; Vos, M. de; Wal, E. van der; Weeren, R. van; Weggemans, H.; Weltevrede, P.; White, S.; Wijnholds, S.J.; Wilhelmsson, T.; Wucknitz, O.; Yatawatta, S.; Zarka, P.; Zensus, A. & Zwieten, J. van (2013), LOFAR: The LOw-Frequency ARray, Astronomy and Astrophysics 556.
- Garstka, M.; Fish, A.; Celie, P.; Stadnik, M.; Joosten, R.; Perrakis, A.; Veelen, P. van; Ovaa, H.; Zacharias, M. & Neefjes, J. (2013), Peptide selection for binding to MHC class I: insights from structure and molecular dynamics, FEBS Journal 280: 468-468.
- Hassan, C.; Kester, M.G.D.; Ru, A.H. de; Hombrink, P.; Drijfhout, J.W.; Nijveen, H.; Leunissen, J.A.M.; Heemskerk, M.H.M.; Falkenburg, J.H.F. & Veelen, P.A. van (2013), The Human Leukocyte Antigen-presented Ligandome of B Lymphocytes, Molecular and Cellular Proteomics 12(7): 1829-1843.
- Hombrink, P.; Hassan, C.; Kester, M.G.D.; Ru, A.H. de; Bergen, C.A.M. van; Nijveen, H.; Drijfhout, J.W.; Falkenburg, J.H.F.; Heemskerk, M.H.M. & Veelen, P.A. van (2013), Discovery of T Cell Epitopes Implementing HLA-Peptidomics into a Reverse Immunology Approach, Journal of Immunology 190(8): 3869-3877.
- Lampen, M.H.; Hassan, C.; Sluijter, M.; Geluk, A.; Dijkman, K.; Tjon, J.M.; Ru, A.H. de; Burg, S.H. van der; Veelen, P.A. van & Hall, T. van (2013), Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2, Molecular Immunology 53(1-2): 126-131.
- Shi, J.; Willemze, A.; Janssen, G.M.C.; Veelen, P.A. van; Drijfhout, J.W.; Cerami, A.; Huizinga, T.W.J.; Trouw, L.A. & Toes, R.E. (2013), Recognition of citrullinated and carbamylated proteins by human antibodies: specificity, cross-reactivity and the 'AMC-Senshu' method, Annals of the Rheumatic Diseases 72(1): 148-150.
- Fang, Y.; Treffers, E.E.; Li, Y.H.; Tas, A.; Sun, Z.; Meer, Y. van der; Ru, A.H. de; Veelen, P.A. van; Atkins, J.F.; Snijder, E.J. & Firth, A.E. (2012), Efficient-2 frameshifting by mammalian ribosomes to synthesize an additional arterivirus protein, Proceedings of the National Academy of Sciences 109(43): E2920-E2928.
- Jahn, L.; Hombrink, P.; Hassan, C.; Kester, M.G.D.; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2012), Two step selection protocol based on the expression of T cell activation marker CD137 increases efficacy in generating high-affinity allo-HLA restricted T cells, Immunology 137: 724-724.
- Kronenberg, D.; Knight, R.R.; Estorninho, M.; Ellis, R.J.; Kester, M.G.; Ru, A. de; Eichmann, M.; Huang, G.C.; Powrie, J.; Dayan, C.M.; Skowera, A.; Veelen, P.A. van & Peakman, M. (2012), Circulating Preproinsulin Signal Peptide-Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill beta-Cells, Diabetes 61(7): 1752-1759.
- Luijn, M.M. van; Loosdrecht, A.A.V. de; Lampen, M.H.; Veelen, P.A. van; Zevenbergen, A.; Kester, M.G.D.; Ru, A.H. de; Ossenkoppele, G.J.; Hall, T. van & Ham, S.M. van (2012), Promiscuous Binding of Invariant Chain-Derived CLIP Peptide to Distinct HLA-I Molecules Revealed in Leukemic Cells, PLoS ONE 7(4): -.
- Zandvliet, M.L.; Kester, M.G.D.; Liempt, E. van; Ru, A.H. de; Veelen, P.A. van; Griffioen, M.; Guchelaar, H.J.; Falkenburg, J.H.F. & Meij, P. (2012), Efficiency and Mechanism of Antigen-specific CD8(+) T-cell Activation Using Synthetic Long Peptides, Journal of Immunotherapy 35(2): 142-153.
- Shi, J.; Janssen, G.M.C.; Veelen, P.A.; Cerami, A.; Huizinga, T.W.J.; Toes, R.E. & Trouw, L.A. (2012), THE 'SENSHU' METHOD OFTEN USED TO DETECT CITRULLINATED PROTEINS DOES NOT DISCRIMINATE BETWEEN CITRULLINATION AND CARBAMYLATION, Annals of the Rheumatic Diseases 71: -.
- Lummel, M. van; Veelen, P.A. van; Zaldumbide, A.; Ru, A. de; Janssen, G.M.C.; Moustakas, A.K.; Papadopoulos, G.K.; Drijfhout, J.W.; Roep, B.O. & Koning, F. (2012), Type 1 Diabetes-associated HLA-DQ8 Transdimer Accommodates a Unique Peptide Repertoire, Journal of Biological Chemistry 287(12): 9514-9524.
- Groot, N.G. de; Heijmans, C.M.C.; Zoet, Y.M.; Ru, A.H. de; Verreck, F.A.; Veelen, P.A. van; Drijfhout, J.W.; Doxiadis, G.G.M.; Remarque, E.J.; Doxiadis, I.I.N.; Koning, F. & Bontrop, R.E. (2011), CONTROL OF HIV-1 REPLICATION: HUMAN LONG-TERM NON-PROGRESSORS AND CHIMPANZEES SHARE MHC CLASS I MOLECULES WITH SIMILAR FUNCTIONAL PROPERTIES, Human Immunology 72: S173-S173.
- Amir, A.L.; Steen, D.M. van der; Hagedoorn, R.S.; Kester, M.G.D.; Bergen, C.A.M. van; Drijfhout, J.W.; Ru, A.H. de; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2011), Allo-HLA-reactive T cells inducing graft-versus-host disease are single peptide specific, Blood 118(26): 6733-6742.
- Hombrink, P.; Hassan, C.; Kester, M.G.D.; Bergen, C.A.M. van; Falkenburg, J.H.F.; Veelen, P.A. van & Heemskerk, M.H.M. (2011), HLA-Peptidomics and the Identification of Clinical Relevant Minor Histocompatibility Antigens, Blood 118(21): 1725-1725.
- Shi, J.; Knevel, R.; Suwannalai, P.; Linden, M.P. van der; Janssen, G.M.C.; Veelen, P.A. van; Levarht, N.E.W.; Helm-van Mil, A.H.M. van der; Cerami, A.; Huizinga, T.W.J.; Toes, R.E.M. & Trouw, L.A. (2011), Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage., Proceedings of the National Academy of Sciences 108(42): 17372-7.
- Boorn, J. van den; Tjin, E.; Picavet, D.; Veen, H. van; Konijnenberg, D.; Swieten, P. van; Veelen, P. van; Meeuwenoord, N.; Filippov, D.; Veen, W. van der; Capel, T. van; Jong, E. de; Drijfhout, J.W.; Reits, E.; Bos, J.; Melief, C. & Luiten, R. (2011), Monobenzone increases the immunogenicity of melanoma cells, and is effective as melanoma immunotherapy, Journal of Investigative Dermatology 131: S107-S107.
- Amir, A.L.; Steen, D.M. van der; Loenen, M.M. van; Hagedoorn, R.S.; Boer, R. de; Kester, M.D.G.; Ru, A.H. de; Lugthart, G.J.; Kooten, C. van; Hiemstra, P.S.; Jedema, I.; Griffioen, M.; Veelen, P.A. van; Falkenburg, J.H.F. & Heemskerk, M.H.M. (2011), PRAME-Specific Allo-HLA-Restricted T Cells with Potent Antitumor Reactivity Useful for Therapeutic T-Cell Receptor Gene Transfer, Clinical Cancer Research 17(17): 5615-5625.
- Akker, J. van den; VanBavel, E.; Geel, R. van; Matlung, H.L.; Tuna, B.G.; Janssen, G.M.C.; Veelen, P.A. van; Boelens, W.C.; Mey, J.G.R. de & Bakker, E.N.T.P. (2011), The Redox State of Transglutaminase 2 Controls Arterial Remodeling, PLoS ONE 6(8).
- Mujico, J.R.; Mitea, C.; Gilissen, L.J.W.J.; Ru, A. de; Veelen, P. van; Smulders, M.J.M. & Koning, F. (2011), Natural variation in avenin epitopes among oat varieties: Implications for celiac disease, Journal of Cereal Science 54(1): 8-12.
- Meenhuis, A.; Veelen, P.A. van; Looper, H. de; Boxtel, N. van; Berge, I.J. van den; Sun, S.M.; Taskesen, E.; Stern, P.; Ru, A.H. de; Adrichem, A.J. van; Demmers, J.; Jongen-Lavrencic, M.; Lowenberg, B.; Touw, I.P.; Sharp, P.A. & Erkeland, S.J. (2011), MiR-17/20/93/106 promote hematopoietic cell expansion by targeting sequestosome 1-regulated pathways in mice, Blood 118(4): 916-925.
- Boorn, J.G. van den; Picavet, D.I.; Swieten, P.F. van; Veen, H.A. van; Konijnenberg, D.; Veelen, P.A. van; Capel, T. van; Jong, E.C. de; Reits, E.A.; Drijfhout, J.W.; Bos, J.D.; Melief, C.J.M. & Luiten, R.M. (2011), Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy, Journal of Investigative Dermatology 131(6): 1240-1251.
- Bakker, E.N.T.P.; Akker, J. van den; Geel, R. van; Matlung, H.L.; Janssen, G.M.C.; Veelen, P.A. van; Boelens, W.C.; Mey, J.G.R. de & VanBavel, E. (2011), The Redox State of Transglutaminase Controls Arterial Remodeling, FASEB Journal 25: -.
- Nijveen, H.; Kester, M.G.D.; Hassan, C.; Viars, A.; Ru, A.H. de; Jager, M. de; Falkenburg, J.H.F.; Leunissen, J.A.M. & Veelen, P.A. van (2011), HSPVdb-the Human Short Peptide Variation Database for improved mass spectrometry-based detection of polymorphic HLA-ligands, Immunogenetics 63(3): 143-153.
- Kessler, J.H.; Khan, S.; Seifert, U.; Gall, S. le; Chow, K.M.; Paschen, A.; Bres-Vloemans, S.A.; Ru, A. de; Montfoort, N. van; Franken, K.L.M.C.; Benckhuijsen, W.E.; Brooks, J.M.; Hall, T. van; Ray, K.; Mulder, A.; Doxiadis, I.I.N.; Swieten, P.F. van; Overkleeft, H.S.; Prat, A.; Tomkinson, B.; Neefjes, J.; Kloetzel, P.M.; Rodgers, D.W.; Hersh, L.B.; Drijfhout, J.W.; Veelen, P.A. van; Ossendorp, F. & Melief, C.J.M. (2011), Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes, Nature Immunology 12(1): 45U67.
- Mitea, C.; Salentijn, E.M.J.; Veelen, P. van; Goryunova, S.V.; Meer, I.M. van der; Broeck, H.C. van den; Mujico, J.R.; Monserrat, V.; Gilissen, L.J.W.J.; Drijfhout, J.W.; Dekking, L.; Koning, F. & Smulders, M.J.M. (2010), A Universal Approach to Eliminate Antigenic Properties of Alpha-Gliadin Peptides in Celiac Disease, PLoS ONE 5(12).
- Cavalli, S.; Houben, A.J.S.; Albers, H.M.H.G.; Tilburg, E.W. van; Ru, A. de; Aoki, J.; Veelen, P. van; Moolenaar, W.H. & Ovaa, H. (2010), Development of an Activity-Based Probe for Autotaxin, ChemBioChem 11(16): 2311-2317.
- Florea, B.I.; Verdoes, M.; Li, N.; Linden, W.A. van der; Geurink, P.P.; Elst, H. van den; Hofmann, T.; Ru, A. de; Veelen, P.A. van; Tanaka, K.; Sasaki, K.; Murata, S.; Dulk, H. den; Brouwer, J.; Ossendorp, F.A.; Kisselev, A.F. & Overkleeft, H.S. (2010), Activity-Based Profiling Reveals Reactivity of the Murine Thymoproteasome-Specific Subunit beta 5t, Cell Chemistry Biology 17(8): 795-801.
- Groot, N.G. de; Heijmans, C.M.C.; Zoet, Y.M.; Ru, A.H. de; Verreck, F.A.; Veelen, P.A. van; Drijfhout, J.W.; Doxiadis, G.G.M.; Remarque, E.J.; Doxiadis, I.I.N.; Rood, J.J. van; Koning, F. & Bontrop, R.E. (2010), AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz, Proceedings of the National Academy of Sciences 107(34): 15175-15180.
- Groot, N.G. de; Heijmans, C.M.C.; Zoet, Y.M.; Ru, A.H. de; Verreck, F.A.; Veelen, P.A. van; Drijfhout, J.W.; Doxiadis, G.G.M.; Remarque, E.J.; Doxiadis, I.I.N.; Koning, F. & Bontrop, R.E. (2010), Control of HIV-1 replication: human long-term non-progressors and chimpanzees share MHC class I molecules with similar functional properties, Tissue Antigens 75(5): 485-485.
- Oliveira, C.C.; Veelen, P.A. van; Querido, B.; Ru, A. de; Sluijter, M.; Laban, S.; Burg, S.H. van der; Offringa, R. & Hall, T. van (2010), The nonpolymorphic MHC Qa-1(b) mediates CD8(+) T cell surveillance of antigen-processing defects, Journal of Experimental Medicine 207(1): 207-221.
- Oliveira, C.C.; Veelen, P.A. van; Querido, B.; Ru, A. de; Sluijter, M.; Laban, S.; Burg, S.H. van der; Offringa, R. & Hall, T. van (2010), The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.
- Mitea C, Kooy-Winkelaar Y, van Veelen P, de Ru A, Drijfhout JW, Koning F & Dekking L (2008), Fine specificity of monoclonal antibodies against celiac disease-inducing peptides in the gluteome, American Journal of Clinical Nutrition 88(4).
- Wiesner M, Stepniak D, de Ru AH, Moustakis AK, Drijfhout JW, Papadopoulos GK, van Veelen PA & Koning F (2008), Dominance of an alternative CLIP sequence in the celiac disease associated HLA-DQ2 molecule, Immunogenetics 60(9).
- Dekking EHA, Van Veelen PA, de Ru A, Kooy-Winkelaar EMC, Groneveld T, Nieuwenhuizen WF & Koning F (2008), Microbial transglutaminases generate T cell stimulatory epitopes involved in celiac disease, Journal of Cereal Science 47(2).
- Stepniak D, Wiesner M, de Ru AH, Moustakas AK, Drijfhout JW, Papadopoulos GK, van Veelen PA & Koning F (2008), Large-scale characterization of natural ligands explains the unique gluten-binding properties of HLA-DQ2, Journal of Immunology 180(5).
- van Bergen CAM, Kester MGD, Jedema I, Heemskerk MHM, van Luxemburg-Heijs SAP, Kloosterboer FM, Marijt WAE, de Ru AH, Schaafsma MR, Willemze R, van Veelen PA & Falkenburg JHF (2007), Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene, Blood 109(9).
- Raijmakers R, Zendman AJW, Egberts WV, Vossenaar ER, Raats J, Soede-Huijbregts C, Rutjes FPJT, van Veelen PA, Drijfhout JW & Pruijn GJM (2007), Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro, Journal of Molecular Biology 367(4).
- Kessler JH, Bres-Vloemans SA, van Veelen PA, de Ru A, Huijbers IJG, Camps M, Mulder A, Offringa R, Drijfhout JW, Leeksma OC, Ossendorp F & Melief CJM (2006), BCR-ABL fusion regions as a source of multiple leukemia-specific CD8(+) T-cell epitopes, Leukemia 20(10).
- Stepniak D, Spaenij-Dekking L, Mitea C, Moester M, de Ru A, Baak-Pablo R, van Veelen P, Edens L & Koning F (2006), Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease, AJP - Gastrointestinal and Liver Physiology 291(4).
- Smyth LJC, Elkord E, Taher TEI, Jiang HR, Burt DJ, Clayton A, van Veelen PA, de Ru A, Ossendorp F, Melief CJM, Drijfhout JW, Dermime S, Hawkins RE & Stern PL (2006), CD8 T-cell recognition of human 5T4 oncofetal antigen, International Journal of Cancer 119(7).
- Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P & Neefjes JJ (2006), Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy, Journal of Experimental Medicine 203(5).
- Hall, T. van; Wolpert, E.Z.; Veelen, P. van; Laban, S.; Veer, M. van der; Roseboom, M.; Bres, S.; Grufman, P.; Ru, A. de; Meiring, H.; Jong, A. de; Franken, K.; Teixeira, A.; Valentijn, R.; Drijfhout, J.W.; Koning, F.; Camps, M.; Ossendorp, F.; Karre, K.; Ljunggren, H.G.; Melief, C.J.M. & Offringa, R. (2006), Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants, Nature Medicine 12(4).
- van Herpen TWJM, Goryunova SV, van der Schoot J, Mitreva M, Salentijn E, Vorst O, Schenk MF, van Veelen PA, Koning F, van Soest LJM, Vosman B, Bosch D, Hamer RJ, Gilissen LJWJ & Smulders MJM (2006), Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopes, BMC Genomics 7.
- Hays JP, van Selm S, Hoogenboezem T, Estevao S, Eadie K, van Veelen P, Tommassen J, van Belkum A & Hermans PWM (2005), Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms, Journal of Bacteriology 187(23).
- Pinkse GGM, Tysma OHM, Bergen CAM, Kester MGD, Ossendorp F, van Veelen PA, Keymeulen B, Pipeleers D, Drijfhout JW & Roep BO (2005), Autoreactive CD8 T cells associated with beta cell destruction in type 1 diabetes, Proceedings of the National Academy of Sciences 102(51).
- Spaenij-Dekking L, Kooy-Winkelaar Y, Van Veelen P, Drijfhout JW, Jonker H, Van Soest L, Smulders MJM, Bosch D, Gilissen LJWJ & Koning F (2005), Natural variation in toxicity of wheat: Potential for selection of nontoxic varieties for celiac disease patients, Gastroenterology 129(3).
- Stepniak D, Vader LW, Kooy Y, van Veelen PA, Moustakas A, Papandreou NA, Eliopoulos E, Drijfhout JW, Papadopoulos GK & Koning F (2005), T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1, Immunogenetics 57(1-2).
- Posthuma EFM, Van Bergen CAM, Kester MGD, de Paus RA, van Veelen PA, de Ru AH, Drijfhout JW, Lurvink EGA, Willemze R & Falkenburg JHF (2004), Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated, Haematologica 89(9).
- Muntasell A, Carrascal M, Alvarez I, Serradell L, van Veelen P, Verreck FAW, Koning F, Abian J & Jaraquemada D (2004), Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: Strong influence of invariant chain and HLA-DM expression on the nature of ligands, Journal of Immunology 173(2).
- Verdijk P, van Veelen PA, de Ru AH, Hensbergen PJ, Mizuno K, Koerten HK, Koning F, Tensen CP & Mommaas AM (2004), Morphological changes during dendritic cell maturation correlate with cofilin activation and translocation to the cell membrane, European Journal of Immunology 34(1).
- Vader LW, Stepniak DT, Bunnik EM, Kooy YMC, De Haan W, Drijfhout JW, Van Veelen PA & Koning F (2003), Characterization of cereal toxicity for celiac disease patients based on protein homology in grains, Gastroenterology 125(4).
- Spierings E, Brickner AG, Caldwell JA, Zegveld S, Tatsis N, Blokland E, Pool J, Pierce RA, Mollah S, Shabanowitz J, Eisenlohr LC, van Veelen P, Ossendorp F, Hunt DF, Goulmy E & Engelhard VH (2003), The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein, Blood 102(2).
- Reits E, Griekspoor A, Neijssen J, Groothuis T, Jalink K, van Veelen P, Janssen H, Calafat J, Drijfhout JW & Neefjes J (2003), Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I, Immunity 18(1).
- Muntasesll A, Carrascal M, Serradell L, van Veelen P, Verreck F, Koning F, Raposo G, Abian J & Jaraquemada D (2002), HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides, Journal of Immunology 169(9).
- Langedijk JPM, van Veelen PA, Schaaper WMM, de Ru AH, Meloen RH & Hulst MM (2002), A structural model of pestivirus E-rns based on disulfide bond connectivity and homology modeling reveals an extremely rare vicinal disulfide, Journal of Virology 76(20).
- Mommaas B, Kamp J, Drijfhout JW, Beekman N, Ossendorp F, van Veelen P, den Haan J, Goulmy E & Mutis T (2002), Identification of a novel HLA-B60-restricted T cell epitope of the minor histocompatibility antigen HA-1 locus, Journal of Immunology 169(6).
- Vader W, Kooy Y, Van Veelen P, De Ru A, Harris D, Benckhuijsen W, Pena S, Mearin L, Drijfhout JW & Koning F (2002), The gluten response in children with Celiac disease is directed toward multiple gliadin and glutenin peptides, Gastroenterology 122(7).
- Joosten SA, van Dixhoorn MGA, Borrias MC, Benediktsson H, van Veelen PA, van Kooten C & Paul LC (2002), Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat, American Journal of Pathology 160(4).
- Vader LW, de Ru A, van der Wal Y, Kooy YMC, Benckhuijsen W, Mearin ML, Drijfhout JW, van Veelen P & Koning F (2002), Specificity of tissue transglutaminase explains cereal toxicity in celiac disease, Journal of Experimental Medicine 195(5).
- Barroso B, Dijkstra R, Geerts M, Lagerwerf F, van Veelen P & de Ru A (2002), On-line high-performance liquid chromatography/mass spectrometric characterization of native oligosaccharides from glycoproteins.
- Charo J, Geluk A, Sundback M, Mirzai B, Diehl AD, Malmberg KJ, Achour A, Huriguchi S, van Meijgaarden KE, Drijfhout JW, Beekman N, van Veelen P, Ossendorp F, Ottenhoff THM & Kiessling R (2001), The identification of a common pathogen-specific HLA class I A*0201-restricted cytotoxic T cell epitope encoded within the heat shock protein 65, European Journal of Immunology 31(12).
- Hiemstra, H.S.; Schloot, N.C.; Veelen, P.A. van; Willemen, S.J.M.; Franken, K.L.M.C.; Rood, J.J. van; Vries, R.R.P. de; Chaudhuri, A.; Behan, P.O.; Drijfhout, J.W. & Roep, B.O. (2001), Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase, Proceedings of the National Academy of Sciences 98(7).
- Kessler JH, Beekman NJ, Bres-Vloemans SA, Verdijk P, van Veelen PA, Kloosterman-Joosten AM, Vissers DCJ, ten Bosch GJA, Kester MGD, Sijts A, Drijfhout JW, Ossendorp F, Offringa R & Melief CJM (2001), Efficient identification of novel HLA-A*0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis, Journal of Experimental Medicine 193(1).
- Hiemstra HS, van Veelen PA, Willemen SJM, Benckhuijsen WE, Geluk A, Roep BO & Drijfhout JW (2000), An HLA class II restricted T-cell is able to recognize about a million different peptides, PEPTIDES FOR THE NEW MILLENNIUM: 681-682.
- Moustakas AK, van de Wal Y, Routsias J, Kooy YMC, van Veelen P, Drijfhout JW, Koning F & Papadopoulos GK (2000), Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
- van Hall T, van Bergen J, van Veelen PA, Kraakman M, Henkamp LC, Koning F, Melief CJM, Ossendorp F & Offringa R (2000), Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin.
- Krijgsveld J, Zaat SAJ, Meeldijk J, van Veelen PA, Fang G, Poolman B, Brandt E, Ehlert JE, Kuijpers AJ, Engbers GHM, Feijen J & Dankert J (2000), Thrombocidins, microbicidal proteins from human flood platelets, are C-terminal deletion products of CXC chemokines.
- Sijts AJAM, Standera S, Toes REM, Ruppert T, Beekman NJCM, van Veelen PA, Ossendorp FA, Melief CJM & Kloetzel PM (2000), MHC class I antigen processing of an Adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.
- Beekman NJ, van Veelen PA, van Hall T, Neisig A, Sijts A, Camps M, Kloetzel PM, Neefjes JJ, Melief CJ & Ossendorp F (2000), Abrogation of CTL epitope processing by single amino acid substitution flanking the C-terminal proteasome cleavage site.
- Wal, Y. van de; Kooy, Y.M.C.; Veelen, P. van; Vader, W.; August, S.A.; Drijfhout, J.W.; Pena, S.A. & Koning, F. (1999), Glutenin is involved in the gluten-driven mucosal T cell response, European Journal of Immunology 29(10): 3133-3139.
- Hiemstra HS, van Veelen PA, Geluk A, Schloot NC, de Vries RRP, Ottenhoff THM, Roep BO & Drijfhout JW (1999), Limitations of homology searching for identification of T-cell antigens with library derived mimicry epitopes, Vaccine 18(3-4): 204-208.
- Hiemstra HS, van Veelen PA, Willemen SJM, Benckhuijsen WE, Geluk A, de Vries RRP, Roep BO & Drijfhout JW (1999), Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases, European Journal of Immunology 29(8): 2385-2391.
- Noort, J.M. van; Veelen, P. van & Hopstaken, F. (1998), Purification of the stress protein alpha B-crystallin and its differentially phosphorylated forms, Journal of Immunological Methods 221(1-2): 159-168.
- Hiemstra HS, van Veelen PA, Schloot NC, Geluk A, van Meijgaarden KE, Willemen SJM, Leunissen JAM, Benckhuijsen WE, Amons R, de Vries RRP, Roep BO, Ottenhoff THM & Drijfhout JW (1998), Definition of natural T cell antigens with mimicry epitopes obtained from dedicated synthetic peptide libraries, Journal of Immunology 161(8): 4078-4082.
- Wal, Y. van de; Kooy, Y.M.C.; Veelen, P.A. van; Pena, S.A.; Mearin, L.M.; Molberg, O.; Lundin, K.E.A.; Sollid, L.M.; Mutis, T.; Benckhuijsen, W.E.; Drijfhout, J.W. & Koning, F. (1998), Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin, Proceedings of the National Academy of Sciences 95(17): 10050-10054.
- Wal, Y. van de; Kooy, Y.; Veelen, P. van; Pena, S.; Mearin, L.; Papadopoulos, G. & Koning, F. (1998), Cutting edge: Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity, Journal of Immunology 161(4): 1585-1588.
- van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Molberg O, Lundin K, Sollid L, Mutis T, Benckhuijsen W, Drijfhout JW & Koning F (1998), T cells from the small intestinal mucosa of coeliac disease patients recognize a unique peptide sequence of gliadin.